Evexia Lifecare Board Approves Q2 FY27 Un-audited Financial Results
Evexia Lifecare Ltd announced that its Board of Directors, in a meeting held on October 24, 2026, approved the Un-audited Standalone & Consolidated Financial Results for the Quarter ended September 30, 2026. The Board also reviewed the Limited Review Report on these results, issued by the Statutory Auditors. The meeting commenced at 7:00 p.m. and concluded at 9:30 p.m. The auditors noted significant increases in credit risk for loans and trade receivables, amounting to ₹735.13 Lakhs and ₹2943.89 Lakhs respectively, for which no expected credit loss assessment was made by management. Consequently, the auditors could not comment on the recoverability of these balances or the potential impact on the financial results.
Key Highlights
- Board approved Un-audited Standalone & Consolidated Financial Results for Q2 FY27.
- Limited Review Report on the results was also approved.
- Auditors raised concerns over recoverability of significant receivables.
- No expected credit loss assessment was performed by management on receivables.
- The Board meeting was held on October 24, 2026.
Price Impact
More from EVEXIA